Quotient acquisition of Arcinova aimed at ‘streamlining’ early development process for biotech and pharma companies

Quotient Sciences, a drug development and manufacturing accelerator with facilities in the UK and the US, has acquired Arcinova, a UK-based multiservice contract development and manufacturing organization (CDMO).